Advertisement
Screener

Establishment Labs Holdings Inc. (ESTA) Operating Cash Flow

2.8 / 5 stars · 68/120 Roast Me

Establishment Labs Holdings Inc. Operating Cash Flow

Establishment Labs Holdings Inc. (ESTA) reported Operating Cash Flow of -$20.91 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.

Financial Statements › Cash Flow › Operating Activities

us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-07

  • Establishment Labs Holdings Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$16.60M.
  • Establishment Labs Holdings Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$4.31M.
  • Establishment Labs Holdings Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$162.00K.
  • Establishment Labs Holdings Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$11.25M.
  • Establishment Labs Holdings Inc. net cash provided by (used in) operating activities for fiscal 2025 was -$50.89M.
  • Establishment Labs Holdings Inc. net cash provided by (used in) operating activities for fiscal 2024 was -$58.52M.
  • Establishment Labs Holdings Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$88.51M.
  • Establishment Labs Holdings Inc. net cash provided by (used in) operating activities for fiscal 2022 was -$52.17M.
Period endNet Cash Provided by (Used in) Operating Activities 3 monthNet Cash Provided by (Used in) Operating Activities 6 monthNet Cash Provided by (Used in) Operating Activities 9 monthNet Cash Provided by (Used in) Operating Activities 12 month
2026-06-30-$16.60M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07
-$20.91M
10-Q · filed 2026-08-07
-$21.07M
derived: sum of 3 quarters · filed 2026-08-07
-$32.32M
derived: sum of 4 quarters · filed 2026-08-07
2026-03-31-$4.31M
10-Q · filed 2026-05-08
-$4.47M
derived: sum of 2 quarters · filed 2026-05-08
-$15.72M
derived: sum of 3 quarters · filed 2026-05-08
-$34.48M
derived: sum of 4 quarters · filed 2026-08-07
2025-12-31-$162.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27
-$11.41M
derived: sum of 2 quarters · filed 2026-02-27
-$30.16M
derived: sum of 3 quarters · filed 2026-08-07
-$50.89M
10-K · filed 2026-02-27
2025-09-30-$11.25M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07
-$30.00M
derived: sum of 2 quarters · filed 2026-08-07
-$50.73M
10-Q · filed 2025-11-07
-$71.48M
derived: sum of 4 quarters · filed 2026-08-07
2025-06-30-$18.75M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07
-$39.48M
10-Q · filed 2026-08-07
-$60.23M
derived: sum of 3 quarters · filed 2026-08-07
-$72.69M
derived: sum of 4 quarters · filed 2026-08-07
2025-03-31-$20.73M
10-Q · filed 2026-05-08
-$41.47M
derived: sum of 2 quarters · filed 2026-05-08
-$53.94M
derived: sum of 3 quarters · filed 2026-05-08
-$68.09M
derived: sum of 4 quarters · filed 2026-05-08
2024-12-31-$20.75M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27
-$33.21M
derived: sum of 2 quarters · filed 2026-02-27
-$47.36M
derived: sum of 3 quarters · filed 2026-02-27
-$58.52M
10-K · filed 2026-02-27
2024-09-30-$12.46M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07
-$26.61M
derived: sum of 2 quarters · filed 2025-11-07
-$37.77M
10-Q · filed 2025-11-07
-$45.91M
derived: sum of 4 quarters · filed 2026-02-27
2024-06-30-$14.15M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07
-$25.31M
10-Q · filed 2025-08-07
-$33.45M
derived: sum of 3 quarters · filed 2026-02-27
-$64.97M
derived: sum of 4 quarters · filed 2026-02-27
2024-03-31-$11.15M
10-Q · filed 2025-05-09
-$19.30M
derived: sum of 2 quarters · filed 2026-02-27
-$50.81M
derived: sum of 3 quarters · filed 2026-02-27
-$79.05M
derived: sum of 4 quarters · filed 2026-02-27
2023-12-31-$8.15M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27
-$39.66M
derived: sum of 2 quarters · filed 2026-02-27
-$67.90M
derived: sum of 3 quarters · filed 2026-02-27
-$88.51M
10-K · filed 2026-02-27
2023-09-30-$31.51M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12
-$59.75M
derived: sum of 2 quarters · filed 2024-11-12
-$80.36M
10-Q · filed 2024-11-12
-$94.38M
derived: sum of 4 quarters · filed 2025-02-28
2023-06-30-$28.24M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07
-$48.85M
10-Q · filed 2024-08-07
-$62.87M
derived: sum of 3 quarters · filed 2025-02-28
-$84.85M
derived: sum of 4 quarters · filed 2025-02-28
2023-03-31-$20.61M
10-Q · filed 2024-05-09
-$34.63M
derived: sum of 2 quarters · filed 2025-02-28
-$56.61M
derived: sum of 3 quarters · filed 2025-02-28
-$67.94M
derived: sum of 4 quarters · filed 2025-02-28
2022-12-31-$14.02M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28
-$36.00M
derived: sum of 2 quarters · filed 2025-02-28
-$47.33M
derived: sum of 3 quarters · filed 2025-02-28
-$52.17M
10-K · filed 2025-02-28
2022-09-30-$21.98M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08
-$33.31M
derived: sum of 2 quarters · filed 2023-11-08
-$38.15M
10-Q · filed 2023-11-08
-$45.86M
derived: sum of 4 quarters · filed 2024-03-04
2022-06-30-$11.33M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09
-$16.17M
10-Q · filed 2023-08-09
-$23.88M
derived: sum of 3 quarters · filed 2024-03-04
-$36.33M
derived: sum of 4 quarters · filed 2024-03-04
2022-03-31-$4.84M
10-Q · filed 2023-05-10
-$12.55M
derived: sum of 2 quarters · filed 2024-03-04
-$25.00M
derived: sum of 3 quarters · filed 2024-03-04
-$25.82M
derived: sum of 4 quarters · filed 2024-03-04
2021-12-31-$7.71M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-04
-$20.16M
derived: sum of 2 quarters · filed 2024-03-04
-$20.98M
derived: sum of 3 quarters · filed 2024-03-04
-$27.53M
10-K · filed 2024-03-04
2021-09-30-$12.46M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09
-$13.27M
derived: sum of 2 quarters · filed 2022-11-09
-$19.82M
10-Q · filed 2022-11-09
-$16.39M
derived: sum of 4 quarters · filed 2023-03-01
2021-06-30-$814.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09
-$7.37M
10-Q · filed 2022-08-09
-$3.93M
derived: sum of 3 quarters · filed 2023-03-01
-$6.98M
derived: sum of 4 quarters · filed 2023-03-01
2021-03-31-$6.55M
10-Q · filed 2022-05-10
-$3.12M
derived: sum of 2 quarters · filed 2023-03-01
-$6.17M
derived: sum of 3 quarters · filed 2023-03-01
-$12.26M
derived: sum of 4 quarters · filed 2023-03-01
2020-12-31$3.43M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01
$387.00K
derived: sum of 2 quarters · filed 2023-03-01
-$5.71M
derived: sum of 3 quarters · filed 2023-03-01
-$12.51M
10-K · filed 2023-03-01
2020-09-30-$3.05M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09
-$9.14M
derived: sum of 2 quarters · filed 2021-11-09
-$15.94M
10-Q · filed 2021-11-09
-$19.97M
derived: sum of 4 quarters · filed 2022-03-01
2020-06-30-$6.09M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30
-$12.90M
10-Q · filed 2021-07-30
-$16.92M
derived: sum of 3 quarters · filed 2022-03-01
-$27.82M
derived: sum of 4 quarters · filed 2022-03-01
2020-03-31-$6.80M
10-Q · filed 2021-05-06
-$10.83M
derived: sum of 2 quarters · filed 2022-03-01
-$21.72M
derived: sum of 3 quarters · filed 2022-03-01
-$28.79M
derived: sum of 4 quarters · filed 2022-03-01
2019-12-31-$4.03M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01
-$14.92M
derived: sum of 2 quarters · filed 2022-03-01
-$21.98M
derived: sum of 3 quarters · filed 2022-03-01
-$29.98M
10-K · filed 2022-03-01
2019-09-30-$10.90M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09
-$17.96M
derived: sum of 2 quarters · filed 2020-11-09
-$25.96M
10-Q · filed 2020-11-09
-$34.44M
derived: sum of 4 quarters · filed 2020-11-09
2019-06-30-$7.06M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07
-$15.06M
10-Q · filed 2020-08-07
-$23.54M
derived: sum of 3 quarters · filed 2020-08-07
-$34.04M
derived: sum of 4 quarters · filed 2020-08-07
2019-03-31-$8.00M
10-Q · filed 2020-05-08
-$16.48M
derived: sum of 2 quarters · filed 2020-05-08
-$26.97M
derived: sum of 3 quarters · filed 2020-05-08
-$35.95M
derived: sum of 4 quarters · filed 2020-05-08
2018-12-31-$8.48M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16
-$18.98M
derived: sum of 2 quarters · filed 2020-03-16
-$27.95M
derived: sum of 3 quarters · filed 2020-03-16
-$33.88M
10-K · filed 2020-03-16
2018-09-30-$10.49M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12
-$19.47M
derived: sum of 2 quarters · filed 2019-11-12
-$25.41M
10-Q · filed 2019-11-12
-$33.55M
derived: sum of 4 quarters · filed 2019-11-12
2018-06-30-$8.98M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13
-$14.91M
10-Q · filed 2019-08-13
-$23.05M
derived: sum of 3 quarters · filed 2019-08-13
-$32.08M
derived: sum of 4 quarters · filed 2019-08-13
2018-03-31-$5.93M
10-Q · filed 2019-05-15
-$14.07M
derived: sum of 2 quarters · filed 2019-05-15
-$23.10M
derived: sum of 3 quarters · filed 2019-05-15
2017-12-31-$8.14M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-20
-$17.17M
derived: sum of 2 quarters · filed 2019-03-20
-$31.97M
10-K · filed 2019-03-20
2017-09-30-$9.03M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13
-$23.83M
10-Q · filed 2018-11-13
2017-06-30-$14.80M
10-Q · filed 2018-09-13

Similar stocks

Stock NameCountryMarket CapPE Ratio
Cadre Holdings, Inc. (CDRE)United States$1.123B33.88
Enovis CORP (ENOV)United States$1.053B-1.18
Anteris Technologies Global Corp. (AVR)United States$0.746B
Sanara MedTech Inc. (SMTI)United States$0.323B-6.81
Inogen Inc (INGN)United States$0.139B-7.00
Conexeu Sciences Inc. (CNXU)United States$0.111B
NutriBand Inc. (NTRB)United States$0.109B
LAKELAND INDUSTRIES INC (LAKE)United States$0.104B-4.21
Safe Pro Group Inc. (SPAI)United States$0.090B
MYOMO, INC. (MYO)United States$0.065B-2.85